Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

methyldeoxyspergualin

Known as: MeDSG, 15-deoxy-11-O-methylspergualin, deoxymethyspergualin 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Major histocompatibility complex class I‐bound antigenic peptides generated in the cytosol are translocated into the ER by TAP… Expand
1999
1999
Difficulty in preventing rejection of fetal pig islet-like cell clusters (ICCs) transplanted into pigs using traditional forms of… Expand
1999
1999
Deoxyspergualin (DSG) has both antitumor and immunosuppressive activities. We explored the mechanism of DSG activities using an… Expand
1998
1998
Deoxyspergualin (DSG) has been found to have an antitumour and immunosuppressive activity. However, the precise mechanism of… Expand
1998
1998
Deoxyspergualin (DSG), an analogue of spermidin, is a potent immunosuppressive drug with an action quite distinct from that of… Expand
1998
1998
Abstract: In clinical practice, graft rejection in small-bowel transplantation should be diagnosed before irreversible condition… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 5
1995
1995
15-Deoxy-11-O-methylspergualin (MeDSG) is an analogue of 15-deoxyspergualin, which has potent immunosuppressive activity. The… Expand
  • figure 2
  • figure 1
  • table 1
  • figure 3
  • figure 4
1992
1992
The effect of deoxymethylspergualin (MeDSG) on in vitro human lymphocyte response was assessed in comparison with FK506 and… Expand
Highly Cited
1992
Highly Cited
1992
Deoxyspergualin, an analog of spergualin, has been known as a novel immunosuppressive agent with strong immunosuppressive… Expand
Highly Cited
1989
Highly Cited
1989
The effects of 15-deoxyspergualin (DSG) and its derivative deoxymethylspergualin (MeDSG), which is more stable than DSG in… Expand